Ringraf 1.0mg Tablet is used along with other medicines to prevent your body from rejecting a new organ (e.g., liver, kidney, or heart) after transplant. It does so by weakening your body’s immune system, so it does not attack the new organ. This medication belongs to a class of drugs known as immunosuppressants.

Ringraf 1.0mg Tablet is used to prevent the body rejecting the organ that is transplanted

Uses of Ringraf Tablet

Prevention of organ rejection in transplant patients

Benefits of Ringraf Tablet

In Prevention of organ rejection in transplant patients

Ringraf 1.0mg Tablet belongs to a group of medicines known as immunosuppressants. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine weakens your immune response (which usually fights infection) and reduces the chance of your body attacking the transplanted organ. It is used in combination with other medicines to make it much more likely that your transplant operation will be successful. You should continue taking the medicine and should not stop it until your doctor says so.

Side effects of Ringraf Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Ringraf

Increased glucose level in blood
Kidney damage
Insomnia (difficulty in sleeping)
Tremors
High blood pressure
Infection

How to use Ringraf Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ringraf 1.0mg Tablet is to be taken empty stomach.

How Ringraf Tablet works

Ringraf 1.0mg Tablet is an immunosuppressant. It works by suppressing your body’s immune response following the transplant of an organ (e.g., liver, kidney, heart). This helps your body to accept the new organ as if it were your own.

Safety advice

Alcohol

UNSAFE

It is unsafe to consume alcohol with Ringraf 1.0mg Tablet.

Pregnancy

CONSULT YOUR DOCTOR

Ringraf 1.0mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Ringraf 1.0mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

UNSAFE

Ringraf 1.0mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

CAUTION

Ringraf 1.0mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Ringraf 1.0mg Tablet may be needed. Please consult your doctor.

Liver

CAUTION

Ringraf 1.0mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Ringraf 1.0mg Tablet may be needed. Please consult your doctor.

What if you forget to take Ringraf Tablet?

If you miss a dose of Ringraf 1.0mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

No substitutes found for this medicine

Quick tips

Ringraf 1.0mg Tablet is used to prevent organ rejection in transplant patients.
It may take 3 to 4 months for the medication to work. Keep taking it as prescribed.
Your doctor may get regular blood tests done to check the levels of blood cells in your blood. Inform your doctor if you experience unexplained bruising or bleeding, sore throat, mouth ulcers, fever, or general illness.
Your doctor may monitor your kidney function regularly. Drink 8 to 10 glasses of water per day to help with your kidney function.
Do not stop taking Ringraf 1.0mg Tablet without talking to your doctor first.

Fact Box

Chemical Class

Macrolide Lactams

Habit Forming

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Immunosuppressant- Calcineurin inhibitors

Patient concerns

Nephrologist considered for consulting Function of kidney transplant patients suffering from tuberculosis

Dr. Praveen Pushkar

Urology

Get kidney function test done

Difficulty in excretory, and rejection of stool.

Dr. Aanchal Maheshwari

Ayurveda

take triphala churan 1 spoon at night wioth abhyarishtam 20 ml mixed with water

Dear respected sir/madam, my uncle is suffering from alcoholic liver cirrhosis and ascites due to prolonng drinking. Water is accumulated around the belly. Less ddesire to eat anything. Doctor is saying for liver transplant. Could please suggest the best treatment available in allopathy to treat this problem. Thank you very very much.

Dr. Pushkar Mani

Physician

liver transplant only, consult in ILBS delhi

Prevention of acene and pimples

Dr. Manju Singh

Homeopathy

Wash acne-prone areas only twice a day. Washing removes excess oil and dead skin cells. But too much washing can irritate the skin. Wash affected areas with a gentle cleanser and use oil-free, water-based skin care products. Use non- oily makeup. Choose oil-free cosmetics that won't clog pores. Remove makeup before going to bed. Going to sleep with cosmetics on your skin can clog your pores. Avoid touching or picking at the problem areas. Doing so can trigger more acne. Always use a clean towel or cloth to wipe your face. Always keep your hands clean and wash them regularly so that you may not touch your skin with dirty hands.

FAQs

Q. Is Ringraf 1.0mg Tablet an antibiotic?

Yes, Ringraf 1.0mg Tablet is a type of antibiotic which belongs to a group of medicines called macrolides. It is mostly used after organ transplantation. This medicine’s immune-suppressing property helps prevent organ rejection after kidney, heart, or liver transplant.

Q. Which vaccines should not be taken while taking Ringraf 1.0mg Tablet?

You should avoid taking any live vaccines (vaccines that use pathogens that are still alive, but are attenuated, that is, weakened) while taking Ringraf 1.0mg Tablet. These may include vaccinations for measles, mumps, rubella, BCG (TB vaccine), yellow fever, chicken pox and typhoid. You should also avoid taking polio drops (by mouth) or flu vaccine (through nose).

Q. Who should not take Ringraf 1.0mg Tablet?

Patients who are allergic to it or have a weak immune system, high blood pressure, and kidney failure should avoid Ringraf 1.0mg Tablet. This medicine should also be avoided in pregnant or breastfeeding women, and in people who plan to receive any live vaccines (e.g. MMR vaccine).

Q. What should I tell my doctor before taking Ringraf 1.0mg Tablet?

Inform your doctor if you are pregnant, have allergies, long-term infection, high blood sugar, or high blood pressure. You should also inform your doctor if you have high blood potassium levels or a weakened immune system. Tell your doctor if you have a history of any medication, have recently received, or are scheduled to receive a live vaccine.

Q. What should I be aware of before I start taking Ringraf 1.0mg Tablet?

This medicine suppresses the immune system and hence there is always an increased risk of infection. Moreover, in some cases, Ringraf 1.0mg Tablet can increase the risk of some kind of cancer like skin and lymph gland cancer (lymphoma). It can lower the ability of your immune system to fight infections. Consult your doctor before you start taking this medication and in case you notice any symptoms of infections like fever, sweats or chills, cough or flu-like symptoms, muscle aches, warm, red, or painful areas on your skin.

Q. Does Ringraf 1.0mg Tablet have an abuse potential?

No, Ringraf 1.0mg Tablet does not have abuse potential and thus, is not a controlled substance. Controlled substances have potential for abuse so they need permission from authorities and doctors for use.

Show less

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1822.
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 972.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1305-309.
Tacrolimus monohydrate. Camberley, Surrey: Sandoz Limited; 2010 [revised 27 Mar. 2017]. [Accessed 23 Jan. 2019] (online) Available from:
Tacrolimus. Princeton, New Jersey: Sandoz Inc; 2009. [Accessed 06 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation. Tacrolimus. [Accessed 06 Aug. 2023]. (online) Available from:
Tacrolimus [package Insert]. Karapakkam, Chennai: The Madras Pharmaceuticals; 2020. [Accessed 06 Aug. 2023]. (online) Available from:

Marketer details

Name: Rindz Pharma

Address: 69, H.V Towers, Valluvar Salai, Arumbakkam, Chennai - 600106

Country of origin: India

MRP

₹390

Inclusive of all taxes

10.0 tablets in 1 strip

SOLD OUT

Notify me

We provide you with authentic, trustworthy and relevant information

Have issue with the content?

Ringraf 1.0mg Tablet

Product introduction